Ceredex Value Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-101,880
Closed -$15M 193
2026
Q1
$15M Buy
101,880
+39,576
+64% +$6.43M 0.47% 93
2025
Q4
$12.1M Buy
+62,304
New +$14.8M 0.37% 132
2018
Q3
Sell
-1,725,841
Closed -$76M 186
2018
Q2
$76M Sell
1,725,841
-716,271
-29% -$33M 0.87% 43
2018
Q1
$112M Buy
+2,442,112
New +$121M 1.33% 4

Other funds holding ORCL

Ceredex Value Advisors's ORCL Position: Q2 2026 in Review

Ceredex Value Advisors sold out of Oracle (ORCL) in Q2 2026, closing a stake of 101,880 shares — an estimated $15M sold.

Ceredex Value Advisors first reported a position in ORCL in Q1 2018 and held it in 4 quarters. The position peaked at $112M in Q1 2018. 3,525 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Ceredex Value Advisors reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • Ceredex Value Advisors sold 101,880 Oracle shares in Q2 2026, an estimated $15M.
  • Ceredex Value Advisors first reported a position in Oracle in Q1 2018 and held it in 4 quarters.
  • Ceredex Value Advisors's Oracle position peaked at $112M in Q1 2018.
  • 3,525 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.